Month: July 2011

FDA Questions Insomnia Drug

Transcept Pharmaceuticals Inc received a Complete Response Letter from the US Food and Drug Administration (FDA) regarding the resubmitted New Drug Application (NDA) for Intermezzo (zolpidem tartrate sublingual tablet). In the Complete Response

Read More

Polysomnography Equipment Survey

Sleep Review is conducting an anonymous survey about polysomnography equipment. The seven-question survey is designed to give polysomnography equipment users information about the quality of various systems and software. Results of the survey wi

Read More